价格透明时代的烧伤医疗筹资:验证状态是否传递议价能力信号?
研究分析2021-2022年烧伤相关DRG(927、928、929、933、934、935)的商业费率,共纳入1541家医院的170738条费率。同一DRG院内及院间费率差异约达3倍,烧伤中心状态与较高费率独立相关(DRG 935除外),HHI是商业费率的最大预测因子(P < .001)。
要点
- 同一DRG的商业费率在院内和院间差异约达3倍,DRG 927变异最大。
- 除DRG 935外,烧伤中心状态与较高费率独立相关。
- HHI是商业费率的最大预测因子(P < .001)。
核心结论
- 住院烧伤治疗的协商价格差异很大,经ABA验证的中心以及处于更集中或垄断市场的烧伤中心获得更高费率。
研究设计与样本
- 将2021-2022年烧伤相关DRG 927、928、929、933、934、935的所有可用商业费率与医院层面变量、ABA验证状态及HHI数据合并分析。
- 共纳入1541家 unique 医院发布的170738条费率。
- 对DRG 927(最密集的烧伤入院)拟合线性混合效应模型,以费用为结局,协变量包括HHI、计划类型、安全网状态、营利状态、验证状态、农村状态和教学医院状态,随机截距允许个体烧伤中心。
主要发现
- 所有DRG中,同一DRG的商业报销费率在院内差异约达3倍。
- 不同医院间所有DRG的费率差异约达3倍,DRG 927变异最大。
- 调整设施层面因素后,除DRG 935外,烧伤中心状态与所有DRG的较高报销费率独立相关。
- HHI是商业费率的最大预测因子(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Price Transparency Rule of 2021 forced payors and hospitals to publicly disclose negotiated prices to foster competition and reduce the cost. Burn care is costly and concentrated at less than 130 centers in the US. We aimed to analyze geographic price variations for inpatient burn care and measure the effects of American Burn Association (ABA) verification status and market concentration on prices. All available commercial rates for 2021-2022 for burn-related diagnosis-related groups (DRGs) 927, 928, 929, 933, 934, and 935 were merged with hospital-level variables, ABA verification status, and Herfindahl-Hirschman Index (HHI) data. For the DRG 927 (most intensive burn admission), a linear mixed effects model was fit with cost as the outcome and the following variables as covariates: HHI, plan type, safety net status, profit status, verification status, rural status, and teaching hospital status. Random intercepts allowed for individual burn centers. There were 170,738 rates published from 1541 unique hospitals. Commercial reimbursement rates for the same DRG varied by a factor of approximately three within hospitals for all DRGs. Similarly, rates across different hospitals varied by a factor of 3 for all DRGs, with DRG 927 having the most variation. Burn center status was independently associated with higher reimbursement rates adjusting for facility-level factors for all DRGs except for 935. Notably, HHI was the largest predictor of commercial rates (P < .001). Negotiated prices for inpatient burn care vary widely. ABA-verified centers garner higher rates along with burn centers in more concentrated/monopolistic markets.
引用
- Stanton EW, Pedreira R, Rizk N, et al. Burn Care Funding in the Era of Price Transparency-Does Verification Signal Bargaining Power? J Burn Care Res. 2024. PMID: 38733210. doi:10.1093/jbcr/irae078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。